Clinician-Guided Sildenafil Troche Therapy

Telehealth Clinical Evaluation

A licensed U.S. clinician reviews your medical history, current medications, and reported symptoms to determine whether sildenafil therapy may be clinically appropriate.

Clinician-Directed Care Determination

All treatment decisions—including whether to prescribe sildenafil, formulation selection, dosing, and frequency—are made solely by the evaluating clinician based on individual assessment and established medical standards.

Prescription Medication Included (If Prescribed)

When clinically appropriate and prescribed, sildenafil is dispensed pursuant to a valid prescription and fulfilled by licensed U.S.-based pharmacies that dispense FDA-approved medications intended for human use.

Discreet Home Delivery

Prescribed medications are shipped in secure, unbranded packaging to support patient privacy and confidentiality.

Follow-Up Care & Ongoing Access

Patients have continued access to clinician support through the secure patient portal for care-related questions or follow-up, when clinically indicated.

Secure Clinician Messaging

HIPAA-compliant messaging is available through the patient portal to support care coordination and clinician communication.

Status: Prescription [RX] Only Care – Telehealth Evaluation Required.

Sildenafil should not be used by individuals taking nitrates or certain cardiovascular medications.
This medication is not appropriate for everyone. A licensed clinician reviews medical history, current medications, and relevant risk factors to determine clinical appropriateness.

Sildenafil therapy may be considered for adult men who report symptoms consistent with erectile dysfunction and who are evaluated by a licensed clinician to determine medical appropriateness.

During evaluation, some individuals may report symptoms such as:

• Difficulty achieving or maintaining an erection

• Reduced erectile firmness

• Inconsistent erectile response during sexual activity

• Erectile changes associated with medical conditions, stress, or aging

Symptom presence alone does not determine eligibility. Prescription is based on clinician assessment, medical history, current medications, and contraindication screening.

Method: Oral troche (dissolves in the mouth)

Administration Context:
Troches are placed in the mouth and allowed to dissolve as directed by the prescribing clinician. Dosing instructions, timing, and frequency are individualized and provided as part of the care plan.

Sildenafil does not initiate erections on its own and requires sexual stimulation to exert its intended physiological effect. Patients should follow all clinician instructions and pharmacy guidance.

Active Ingredient:
Sildenafil Citrate USP (prescription-only PDE5 inhibitor)

Inactive Ingredients:
Inactive ingredients vary by pharmacy and formulation and may include standard compounding excipients necessary for troche preparation.

Exact formulation details are determined by the dispensing pharmacy in accordance with applicable regulatory and compounding standards.

Note: As a compounded medication, specific inactive ingredients may vary slightly depending on the pharmacy.